Total Payments
$63,186
2022 Payments
$679.28
Companies
24
Transactions
567
Medicare Patients
542
Medicare Billing
$66,211
Payment Breakdown by Category
Other$44,770 (70.9%)
Food & Beverage$12,444 (19.7%)
Travel$3,792 (6.0%)
Consulting$1,800 (2.8%)
Education$380.58 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $35,640 | 28 | 56.4% |
| Food and Beverage | $12,444 | 502 | 19.7% |
| Honoraria | $9,130 | 6 | 14.4% |
| Travel and Lodging | $3,792 | 14 | 6.0% |
| Consulting Fee | $1,800 | 3 | 2.8% |
| Education | $380.58 | 14 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $24,027 | 89 | $0 (2020) |
| Insmed, Inc. | $15,555 | 43 | $0 (2022) |
| The Medicines Company | $9,368 | 35 | $0 (2017) |
| Paratek Pharmaceuticals, Inc. | $4,220 | 39 | $0 (2022) |
| Gilead Sciences, Inc. | $2,026 | 103 | $0 (2022) |
| ABBVIE INC. | $1,850 | 18 | $0 (2022) |
| ViiV Healthcare Company | $1,579 | 67 | $0 (2022) |
| Merck Sharp & Dohme LLC | $1,448 | 70 | $0 (2022) |
| Janssen Products, LP | $564.21 | 7 | $0 (2019) |
| Theratechnologies Inc. | $476.54 | 23 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $679.28 | 30 | Gilead Sciences, Inc. ($157.42) |
| 2021 | $2,948 | 84 | AbbVie Inc. ($1,762) |
| 2020 | $9,477 | 80 | Paratek Pharmaceuticals, Inc. ($2,995) |
| 2019 | $19,789 | 137 | Insmed, Inc. ($12,734) |
| 2018 | $8,367 | 107 | Allergan Inc. ($6,298) |
| 2017 | $21,926 | 129 | Allergan Inc. ($11,010) |
All Payment Transactions
567 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/14/2022 | SANOFI PASTEUR INC. | — | Food and Beverage | In-kind items and services | $114.74 | General |
| 06/15/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $25.67 | General |
| 06/14/2022 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/07/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $20.60 | General |
| 05/31/2022 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Respiratory | ||||||
| 05/18/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $25.24 | General |
| 04/27/2022 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/20/2022 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA, RECARBRIO | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/19/2022 | MAYNE PHARMA INC. | — | Food and Beverage | In-kind items and services | $22.04 | General |
| 04/12/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $4.66 | General |
| 04/06/2022 | ViiV Healthcare Company | DOVATO (Drug), RUKOBIA | Food and Beverage | In-kind items and services | $23.85 | General |
| Category: HIV | ||||||
| 04/05/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $23.57 | General |
| 03/30/2022 | La Jolla Pharmaceutical Company | XERAVA (Drug) | Food and Beverage | In-kind items and services | $23.66 | General |
| Category: TETRACYCLINE CLASS ANTIBACTERIAL | ||||||
| 03/29/2022 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: HIV | ||||||
| 03/15/2022 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA, RECARBRIO | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/09/2022 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: ANTIBIOTIC | ||||||
| 03/08/2022 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: Respiratory | ||||||
| 03/08/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $5.41 | General |
| 03/02/2022 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/01/2022 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $26.60 | General |
| Category: HIV | ||||||
| 02/23/2022 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: Infections and Infectious Diseases | ||||||
| 02/22/2022 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/16/2022 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: Respiratory | ||||||
| 02/15/2022 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), ISENTRESS, DIFICID | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/08/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $24.99 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 3 | 42 | 73 | $12,271 | $4,187 |
| 2021 | 6 | 188 | 266 | $63,410 | $21,902 |
| 2020 | 6 | 312 | 426 | $113,190 | $40,123 |
Total Patients
542
Total Services
765
Medicare Billing
$66,211
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0407 | Follow-up inpatient consultation, intermediate, physicians typically spend 25 minutes communicating with the patient via telehealth | Office | 2022 | 11 | 33 | $5,214 | $1,873 | 35.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 20 | 29 | $4,582 | $1,431 | 31.2% |
| G0425 | Telehealth consultation, emergency department or initial inpatient, typically 30 minutes communicating with the patient via telehealth | Office | 2022 | 11 | 11 | $2,475 | $882.99 | 35.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 61 | 67 | $30,217 | $10,529 | 34.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 39 | 80 | $12,640 | $4,078 | 32.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 35 | 44 | $10,208 | $3,619 | 35.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 25 | 35 | $5,635 | $2,004 | 35.6% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 11 | 14 | $2,240 | $974.58 | 43.5% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 17 | 26 | $2,470 | $696.93 | 28.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 109 | 116 | $52,316 | $18,587 | 35.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 52 | 96 | $22,272 | $7,949 | 35.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 58 | 81 | $13,041 | $4,613 | 35.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 40 | 59 | $13,865 | $4,584 | 33.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 41 | 57 | $9,006 | $2,967 | 32.9% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 12 | 17 | $2,690 | $1,422 | 52.9% |
About Dr. Silvania Ng, MD
Dr. Silvania Ng, MD is a Infectious Disease healthcare provider based in Cincinnati, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1053386540.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Silvania Ng, MD has received a total of $63,186 in payments from pharmaceutical and medical device companies, with $679.28 received in 2022. These payments were reported across 567 transactions from 24 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($35,640).
As a Medicare-enrolled provider, Ng has provided services to 542 Medicare beneficiaries, totaling 765 services with total Medicare billing of $66,211. Data is available for 3 years (2020–2022), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Location Cincinnati, OH
- Active Since 02/20/2006
- Last Updated 11/19/2014
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1053386540
Products in Payments
- Arikayce (Drug) $14,388
- DALVANCE (Drug) $13,717
- AVYCAZ (Drug) $11,911
- ORBACTIV (Drug) $8,979
- NUZYRA (Drug) $4,220
- DOVATO (Drug) $687.56
- TRIUMEQ (Drug) $680.54
- Biktarvy (Drug) $448.50
- ISENTRESS (Drug) $442.52
- TROGARZO (Drug) $384.03
- MINOCIN IV (Drug) $344.21
- VIBATIV (Drug) $336.24
- ZERBAXA (Drug) $328.48
- DIFICID (Drug) $317.44
- Fetroja (Drug) $316.87
- Xenleta (Drug) $298.48
- PREZCOBIX (Drug) $274.88
- Symtuza (Drug) $267.14
- TEFLARO (Drug) $215.25
- JULUCA (Drug) $192.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Cincinnati
John Cafardi, M.d, M.D
Infectious Disease — Payments: $49,611
Infectious Disease $49,611
Senu Apewokin, M.d, M.D
Infectious Disease — Payments: $11,174
Infectious Disease $11,174
Dr. Francisco Fernandez-Gonzalez, Md, MD
Infectious Disease — Payments: $6,220
Infectious Disease $6,220
Dr. Joseph Klingen, M.d, M.D
Infectious Disease — Payments: $5,557
Infectious Disease $5,557
Moises Huaman Joo, M.d, M.D
Infectious Disease — Payments: $4,285
Infectious Disease $4,285
Lisa Haglund, M.d, M.D
Infectious Disease — Payments: $1,436
Infectious Disease $1,436